全文获取类型
收费全文 | 256939篇 |
免费 | 12999篇 |
国内免费 | 452篇 |
专业分类
耳鼻咽喉 | 3443篇 |
儿科学 | 7728篇 |
妇产科学 | 5186篇 |
基础医学 | 36595篇 |
口腔科学 | 6650篇 |
临床医学 | 20258篇 |
内科学 | 57607篇 |
皮肤病学 | 6668篇 |
神经病学 | 22842篇 |
特种医学 | 7526篇 |
外国民族医学 | 101篇 |
外科学 | 32072篇 |
综合类 | 1091篇 |
一般理论 | 75篇 |
预防医学 | 23408篇 |
眼科学 | 5063篇 |
药学 | 18183篇 |
中国医学 | 787篇 |
肿瘤学 | 15107篇 |
出版年
2023年 | 1403篇 |
2022年 | 949篇 |
2021年 | 3925篇 |
2020年 | 2319篇 |
2019年 | 4439篇 |
2018年 | 8387篇 |
2017年 | 5430篇 |
2016年 | 5443篇 |
2015年 | 6310篇 |
2014年 | 6622篇 |
2013年 | 10608篇 |
2012年 | 18128篇 |
2011年 | 17982篇 |
2010年 | 9131篇 |
2009年 | 6842篇 |
2008年 | 15386篇 |
2007年 | 16411篇 |
2006年 | 15289篇 |
2005年 | 15078篇 |
2004年 | 14007篇 |
2003年 | 12758篇 |
2002年 | 12049篇 |
2001年 | 6216篇 |
2000年 | 6303篇 |
1999年 | 5615篇 |
1998年 | 977篇 |
1997年 | 806篇 |
1996年 | 782篇 |
1995年 | 709篇 |
1992年 | 3239篇 |
1991年 | 2910篇 |
1990年 | 2758篇 |
1989年 | 2518篇 |
1988年 | 2381篇 |
1987年 | 2210篇 |
1986年 | 2103篇 |
1985年 | 1903篇 |
1984年 | 1423篇 |
1983年 | 1204篇 |
1979年 | 1213篇 |
1978年 | 854篇 |
1977年 | 801篇 |
1975年 | 811篇 |
1974年 | 996篇 |
1973年 | 1000篇 |
1972年 | 936篇 |
1971年 | 927篇 |
1970年 | 862篇 |
1969年 | 909篇 |
1968年 | 789篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
41.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep 下载免费PDF全文
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献
42.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
43.
44.
45.
46.
47.
48.
49.
Annals of Nuclear Medicine - Cardiac amyloidosis is a rare disease characterized by amyloid heart deposits and is usually a part of systemic amyloidosis, in relation to systemic light chain (AL)... 相似文献
50.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献